ABROGATE (GPA)

Full Name: Abatacept (CTLA4-Ig) for the Treatment of Relapsing, Non-Severe, Granulomatosis with Polyangiitis (Wegener’s)
Study Dates: 2015-2023
NCT #: NCT02108860
Study Findings: Study results are pending.